actiTENS is the product of a collaboration between engineers from the CEA in Grenoble and the Head of Service of the Pain Evaluation and Treatment Centre at the University Hospital Centre in Grenoble.
actiTENS is a transcutaneous electrical nerve stimulation (TENS) medical device designed to manage chronic pain in adults.
It is a drug-free medical technique that aims to relieve pain via electrical pulses targeting muscular fibre or nerves via electrodes placed on he skin. This pain treatment method is scientifically recognised and validated.
The cases currently used are rigid, bulky, equipped with long cables, worn on a belt or around the neck, producing real physical and psychological discomfort for patients.
actiTENS has been designed to improve the user experience and overcome the inconveniences of present-day TENS.
actiTENS bénéfice du marquage CE
actiTENS allows the stimulation of all areas of the body. Miniature, slim and flexible, it is worn directly on the person and is adapted perfectly to the morphology of each patient.
Invisible under clothing, the actiTENS discreetly accompanies patients in their daily activities, allowing them to return to active life.
SUBLIMED has ISO 13485 certification. actiTENS is a Class II.A Medical Device with CE mark and FDA clearance.
actiTENS is managed via a mobile app available on IOS and Android via a Bluetooth connection.
In order to meet patients’ needs, actiTENS has a large product catalogue: 4 sizes of cables (14, 40, 70, 100 cm), different types and sizes of electrodes (square, round, rectangular), a lumbar electrode, and hypoallergenic sensitive skin electrodes
The actiTENS app has 14 stimulation programmes in order to relieve patients’ pain as best as possible.
actiTENS offers complete autonomy in the management of treatment and enables the monitoring of daily pain via an actiTENS mobile app available on Android and IOS.
The automatic and detailed recording of the history of stimulation sessions and pre and post session monitoring of the level of pain allow the healthcare professional to monitor the patient’s pain and adapt the treatment.
1
SELECT THE PROGRAMME
2
SELECT THE DURATION
3
SELECT THE INTENSITY
AND THAT’S ALL!
The type of treatment and the choice of programme should be decided with your healthcare professional according to your pathology.
Frequency: 100 Hz
Pulse width: 200µs
Default duration: 30 min
Method of action: Inhibition of pain signal
Frequency: 80 Hz
Pulse width: 150µs
Default duration: 30 min
Method of action: Inhibition of pain signal
Frequency: 2 Hz
Pulse width: 250µs
Default duration: 30 min
Method of action: stimulation of the secretion of endorphins for a general analgesic effect.
CHANNEL 1: Gate Control
Frequency: 100 Hz
Pulse width: 200µs
CHANNEL 2: Endorphinic
Frequency: 2 Hz
Pulse width: 200µs
Default duration: 30 min
Method of action: Combined action
• Inhibition of pain signal
• Stimulation of the secretion of endorphins for a general analgesic effect
1st sequence (1/3 of the duration, here 10 min): Gate Control
Frequency: 100 Hz
Pulse width: 150µs
2nd sequence (2/3 of the duration, here 20 min): Endorphinic
Frequency: 2 Hz
Pulse width: 200µs
Default duration: 30 min
Method of action: Combined action
• Inhibition of pain signal
• Stimulation of the secretion of endorphins for a general analgesic effect
1st sequence (duration 3 sec): Gate Control
Frequency: 100 Hz
Pulse width: 150µs
2nd sequence (duration 3 sec): Endorphinic
Frequency: 2 Hz
Pulse width: 200µs
These two sequences are alternated every 3 seconds.
Default duration: 30 min
Method of action: Combined action
• Inhibition of pain signal
• Stimulation of the secretion of endorphins for a general analgesic effect
1st sequence (duration 0.25 sec): Gate Control
Frequency: 100 Hz
Pulse width: 150µs
2nd sequence (duration 0.25 sec): Endorphinic
Frequency: 2 Hz
Pulse width: 200µs
These two sequences are alternated every 0.25 seconds.
Default duration: 30 min
Method of action: Combined action
• Inhibition of pain signal
• Stimulation of the secretion of endorphins for a general analgesic effect
1st sequence (duration 7.5 sec): Gate Control
Increasing frequency: 2 Hz to 80 Hz
Decreasing pulse width: 200 µs to 100 µs
2nd sequence (duration 7.5 sec): Endorphinic
Decreasing frequency: 80 Hz to 2 Hz
Increasing pulse width: 100 µs to 200 µs
These two sequences are alternated every 7.5 seconds.
Default duration: 30 min
Method of action: combined action
• Inhibition of pain signal
• Stimulation of the secretion of endorphins for a general analgesic effect
Frequency: 50 Hz
Pulse width: 250µs
1st sequence (2 sec):
Increasing intensity: 0Ma at the requested intensity
2ndsequence (5 sec):
Increasing intensity (requested intensity)
3rd sequence (1 sec):
Decreasing intensity: intensity requested at 0Ma
4th sequence (12 sec):
No pulse
These sequences are alternated throughout the duration of the programme
Default duration: 30 min
Method of action: Muscular strengthening
Frequency: 80 Hz
Pulse width: 150µs
CHANNEL 1:
1st sequence (1 sec): increasing intensity from 0mA to the requested value
2nd sequence (1 sec): decreasing intensity from the requested value to 0mA
CHANNEL 2:
1st sequence (1 sec): decreasing intensity from the requested value to 0mA
2nd sequence (1 sec): increasing intensity from 0mA to the requested value
Default duration: 30 min
Method of action: comfort
Frequency: 80 Hz
Pulse width: 150µs
CHANNEL 1:
1st sequence (0.2 sec): increasing intensity from 0mA to the requested value
2nd sequence (0.2 sec): decreasing intensity from the requested value to 0mA
CHANNEL 2:
1st sequence (0.2 sec): decreasing intensity from the requested value to 0mA
2nd sequence (0.2 sec): increasing intensity from 0mA to the requested value
Default duration: 30 min
Method of action: comfort
Frequency: 80 Hz
Pulse width: 60µs
Default duration: 30 min
Method of action: Inhibition of pain signal
Frequency: 10 Hz
Pulse width: 180µs
Default duration: 30 min
Method of action: stimulation of the secretion of endorphins for a general analgesic effect
Share the information
The actiTENS system is an assembly of medical devices. Please refer to the instructions for use for more information.
The neurostimulator and the mobile application are regulated health products which carry the CE mark (2797), manufactured by SUBLIMED 813 959 012 RCS Grenoble. Kit assembled by SUBLIMED (within the meaning of Article 22 of Regulation 2017/745).
